NewsBenzinga체크포인트 소프트웨어, 3분기 조정 EPS 2.49달러로 예상치 2.48달러 상회, 매출 6억 6,980만 달러로 예상치 6억 7,203만 달러 하회 체크포인트 소프트웨어, 3분기 조정 EPS 2.49달러로 예상치 2.48달러 상회, 매출 6억 6,980만 달러로 예상치 6억 7,203만 달러 하회 Benzinga 2026.11.02 10:01 (GMT+0) Open on Benzinga Other news TAT Techs Q3 EPS $0.58 Beats $0.40 Estimate, Sales $55.563M Beat $52.752M Estimate Baird Maintains Outperform on Carrier Global, Lowers Price Target to $70 Karyopharm Therapeutics Enters Restructuring Agreement With Lenders, Clearing Path For A Merger With Ayrmid; Secures Commitments For Up To $55M Of Debtor-In-Possession Financing Equinor CEO Says Shipping Costs Have Rapidly Changed, Efficient Market That We Were Used To Is Not There Anymore Kazia Therapeutics Says Two Abstracts Highlighting Paxalisib Tumor And Immune Reprogramming Research Accepted For Poster Presentation At 2026 San Antonio Breast Cancer Symposium DA Davidson Upgrades Franklin Electric to Buy, Raises Price Target to $135
Karyopharm Therapeutics Enters Restructuring Agreement With Lenders, Clearing Path For A Merger With Ayrmid; Secures Commitments For Up To $55M Of Debtor-In-Possession Financing
Equinor CEO Says Shipping Costs Have Rapidly Changed, Efficient Market That We Were Used To Is Not There Anymore
Kazia Therapeutics Says Two Abstracts Highlighting Paxalisib Tumor And Immune Reprogramming Research Accepted For Poster Presentation At 2026 San Antonio Breast Cancer Symposium
